January 22, 2024
Breakthrough T1D Awards $9 Million for Phase 3 Type 1 Diabetes Kidney Disease Clinical Trial, Joins The Kidney Foundation of Canada in Driving Research to Treat Kidney Disease
December 22, 2023
NFL Stars Support Breakthrough T1D and Champion Type 1 Diabetes Awareness through the “My Cause My Cleats” Campaign
December 12, 2023
Breakthrough T1D International Joins Community, Clinical Partners and William J. Clinton Foundation to Improve Type 1 Diabetes Care in India
November 14, 2023
Breakthrough T1D Moves the Type 1 Diabetes Community “Forward” in Honor of World Diabetes Day and National Diabetes Awareness Month
November 8, 2023
Breakthrough T1D Comments on New Disease-Modifying Therapy Research Published in Lancet
November 3, 2023
Breakthrough T1D’s Statement During Today’s Medicare Drug Price Negotiation Program Patient-Focused Listening Session for Insulin Products, Fiasp and Novolog
October 25, 2023
Grant given to the University of Dundee for research in patients with type 1 diabetes with heart failure
October 18, 2023
Breakthrough T1D Encouraged by Results of PROTECT Clinical Trial
October 17, 2023
Breakthrough T1D Chief Scientific Officer Dr. Sanjoy Dutta to Present at ISPAD on Global Type 1 Diabetes Screening
October 16, 2023
A Message to Our Community
